Attend the Opsens sponsored complimentary lunch educational symposium, “Upgrading Coronary Physiologic Approaches: Methods, Myths, and Best Practices” at CRT (Cardiovascular Research Technologies) 2018 Conference in Washington, DC. Opsens offers the first fiber-optic FFR guidewire with nitinol core, providing superior handling, functionality and […]
Category: News & Events
OPSENS ANNOUNCES ELECTION RESULTS FOR THE BOARD OF DIRECTORS AND THE RETIREMENT OF CLAUDE BELLEVILLE
Quebec City, Quebec, January 23, 2018 – Opsens Inc. (“Opsens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) today held its annual general shareholders’ meeting (the “Meeting”) at its head office in Quebec City, Canada. Opsens’ shareholders re-elected Denis M. Sirois, Denis […]
OPSENS REPORTS Q1 2018 RESULTS – RECORD QUARTERLY REVENUES WITH GROWTH IN ALL GEOGRAPHIC REGIONS
Quebec City, Quebec, January 15, 2018 – Opsens Inc. (“Opsens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) today reported its results for the first quarter ended November 30, 2017. Highlights Consolidated revenues reached $6,364,000 for Q1 2018 compared with $3,745,000 for the […]
OPSENS’ JAPANESE PARTNER ZEON MEDICAL PROCEEDS WITH CONVERSION OF US$2 MILLION DEBENTURE
Quebec City, Quebec, November 27, 2017 – Opsens Inc. (“Opsens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) is pleased to announce the conversion of the US$2 million debenture held by Zeon Medical Inc. (“Zeon Medical”), Opsens’ Japanese partner. Zeon Medical has been a client […]
OPSENS REPORTS 2017 RESULTS – CONSOLIDATED REVENUES UP 85% FOR FISCAL 2017
OPSENS REPORTS 2017 RESULTS – CONSOLIDATED REVENUES UP 85% FOR FISCAL 2017 Quebec City, Quebec, November 15, 2017 – Opsens Inc. (“Opsens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) today reported its results for the year ended August 31, 2017. Highlights Record […]
OPSENS GETS TECHNOLOGICAL AWARD
Quebec City, Quebec, October 24, 2017 – Opsens Inc. (“Opsens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) is proud to announce that its wholly owned subsidiary Opsens Solutions has received the first prize in the category “Best Innovative Product – Physics Measurements” […]
VISIT OPSENS MEDICAL AT TCT 2017
Learn more about OptoWire at booth #5014 at the Transcatheter Cardiovascular Therapeutics Conference (TCT) 2017, and attend the Opsens sponsored complimentary lunch educational symposium, “Beyond FFR: New Nonhyperemic Indices in the Cath Lab”. Educational Symposium Objectives: Update on procedures involving challenging patient subsets Examine […]
OPSENS PRESENTS A SHORT FILM AT THE INTERNATIONAL MEDICAL FILM FESTIVAL
OPSENS PRESENTS A SHORT FILM AT THE INTERNATIONAL MEDICAL FILM FESTIVAL Quebec City, Quebec, September 13, 2017 – Opsens Inc. (“Opsens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) is proud to announce that it has been invited to present a short film as part of […]
Opsens – Q3 Results
OPSENS REPORTS Q3 2017 RESULTS ANOTHER RECORD QUARTER WITH REVENUES UP 130% TO $4.9 MILLION Quebec City, Quebec, June 29, 2017 – Opsens Inc. (“Opsens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) today reported its results for the third quarter ended May 31, 2017. Highlights […]
VISIT OPSENS MEDICAL AT THE 13TH ANNUAL C3 CONFERENCE
Learn more about OptoWire Deux at booth #211 at the 13th Annual Complex Cardiovascular Catheter Therapeutics (C3) Conference, and attend the Opsens sponsored complimentary breakfast educational symposium, “Applying Advanced Physiology Technology in the New PCI Era”. This program is geared […]
